These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4292251)

  • 1. Failure of metyrapone to inhibit 11-hydroxylation of 11-deoxycortisol during drug therapy.
    Werk EE; Thrasher K; Choi Y; Sholiton LJ
    J Clin Endocrinol Metab; 1967 Sep; 27(9):1358-60. PubMed ID: 4292251
    [No Abstract]   [Full Text] [Related]  

  • 2. Pituitary-adrenocortical studies in a patient with Cushing's syndrome induced by thymoma.
    Miura K; Sasaki C; Katsushima I; Ohtomo T; Sato S; Demura H; Torikai T; Sasano N
    J Clin Endocrinol Metab; 1967 May; 27(5):631-7. PubMed ID: 4290580
    [No Abstract]   [Full Text] [Related]  

  • 3. [The value of biologic half-life and cortisol secretion rate in the field of cortico-adrenal exploration].
    Revol A; Couchat MC; Tourniaire J; Mornex R; Bizollon CA; Guinet P
    Rev Fr Endocrinol Clin; 1968; 9(4):283-304. PubMed ID: 4302796
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of diphenine on the functional state of the adrenal cortex in patients with Itsenko-Cushing disease].
    Starkova NT; Marova EI; Lemesheva SN; Goncharova VN; Atamanova TM
    Probl Endokrinol (Mosk); 1972; 18(6):35-8. PubMed ID: 4654765
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of the efficiency of 11-beta-hydroxylation of 11-deoxycortisol in human subjects.
    Vermeulen A; Verdonck G; Van der Straeten M; Daneels R
    J Clin Endocrinol Metab; 1967 Mar; 27(3):365-70. PubMed ID: 4290322
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnosis of Cushing's syndrome. The differentiation between adrenocortical hyperplasia and adrenocrotical adenoma by means of lysine-vasopressin.
    Bethge H; Bayer JM; Winkelmann W
    Acta Endocrinol (Copenh); 1969 Jan; 60(1):47-59. PubMed ID: 4308289
    [No Abstract]   [Full Text] [Related]  

  • 7. [Present state of the dynamic studies of the adrenal cortex (excepting and aldosterone function)].
    Bricaire H; Leprat J; Luton JP
    Presse Med (1893); 1968 Nov; 76(45):2157-60. PubMed ID: 4305257
    [No Abstract]   [Full Text] [Related]  

  • 8. [Importance of the study of corticotropin circadian rhythm in the functional symptomatology of the ACTH-adrenal axis].
    Angeli A; Boccuzzi G; Frairia R; Bisbocci D
    Minerva Med; 1974 Jun; 65(46):2499-512. PubMed ID: 4367702
    [No Abstract]   [Full Text] [Related]  

  • 9. Intermittent Cushing's syndrome with anomalous response to dexamethasone.
    Brooks RV; Jeffcoate SL; London DR; Prunty FT; Smith PM
    J Endocrinol; 1966 Sep; 36(1):53-61. PubMed ID: 4288409
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased metabolism of metyrapone in rats pretreated with diphenylhydantoin or phenobarbital.
    Szeberenyi S; Tacconi MT; Garattini S
    Endocrinology; 1969 Sep; 85(3):575-6. PubMed ID: 5793035
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of large doses of reserpine on the hypothalamo-hypophyseal-adrenal system in Itsenko-Cushing's disease].
    Marova EI; Butrova SA; Kolesnikova GS
    Probl Endokrinol (Mosk); 1978; 24(2):17-21. PubMed ID: 205862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cushing's syndrome with dual pituitary-adrenal control.
    Choi Y; Werk EE; Sholiton LJ
    Arch Intern Med; 1970 Jun; 125(6):1045-9. PubMed ID: 4378134
    [No Abstract]   [Full Text] [Related]  

  • 13. A simplified metyrapone test with determination of plasma ll-deoxycortisol (Metyrapone test with plasma S).
    Meikle AW; Jubiz W; Hutchings MP; West CD; Tyler FH
    J Clin Endocrinol Metab; 1969 Jul; 29(7):985-7. PubMed ID: 5793454
    [No Abstract]   [Full Text] [Related]  

  • 14. [Behavior of adrenocorticotropic internal secretions in Cushing's syndrome].
    Silvestrini F; D'Alonzo R
    Schweiz Med Wochenschr; 1970 Oct; 100(40):1680-4. PubMed ID: 4335210
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppression of ACTH by cortisol in dexamethasone-nonsuppressible Cushing's disease.
    Carey RM
    N Engl J Med; 1980 Jan; 302(5):275-9. PubMed ID: 6243171
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of hypothalamic lesions on pituitary-adrenocortical responses to histamine and methopyrapone.
    Katsuki S; Ito M; Watanabe A; Iino K; Yuji S; Kondo S
    Endocrinology; 1967 Nov; 81(5):941-5. PubMed ID: 4293225
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytochrome P450 and steroid 11beta-hydroxylation in mitochondria from human adrenal cortex.
    Wilson LD; Oldham SB; Harding BW
    J Clin Endocrinol Metab; 1968 Aug; 28(8):1143-52. PubMed ID: 4386376
    [No Abstract]   [Full Text] [Related]  

  • 18. Intermittent steroid therapy. Its effect on hypothalamic-pituitary-adrenal function and the response of plasma growth hormone and insulin to stimulation.
    Martin MM; Gaboardi F; Podolsky S; Raiti S; Calcagno PL
    N Engl J Med; 1968 Aug; 279(6):273-8. PubMed ID: 4298259
    [No Abstract]   [Full Text] [Related]  

  • 19. Normal and abnormal function of the hypothalamic-pituitary-adrenocortical system in man.
    Streeten DH; Anderson GH; Dalakos TG; Seeley D; Mallov JS; Eusebio R; Sunderlin FS; Badawy SZ; King RB
    Endocr Rev; 1984; 5(3):371-94. PubMed ID: 6088218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cushing's disease: megadose dexamethasone suppression in a case refractory to medical therapy.
    Warren SE; Westbie DK; Daly R; Bower RH
    South Med J; 1979 Apr; 72(4):412-4. PubMed ID: 219547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.